Restoring Safeguards for Dangerous Abortion Drugs Act
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
This bill would require the HHS Secretary to maintain strict safety protocols (a Risk Evaluation and Mitigation Strategy) for mifepristone, the drug used in medication abortion, and would reverse recent FDA decisions that loosened those protections.
Why it matters: Christian families concerned with protecting unborn life have a direct interest in whether abortion drugs remain tightly regulated or become more accessible; this bill addresses federal oversight of a procedure fundamental to sanctity-of-life convictions.
Topic: Sanctity of life · classifier confidence 95%
What this changes
Amends existing law
Law today: Mifepristone (a medication used in medication abortion) is currently regulated under a risk evaluation and mitigation strategy (REMS) approved by the FDA. The bill references a previously approved strategy that the bill seeks to restore.
If passed: This bill would require the Secretary of Health and Human Services to reinstate a prior risk evaluation and mitigation strategy for mifepristone that was in effect before recent changes. This would likely restore stricter requirements around how the drug is distributed, who can prescribe it, and what safety monitoring is required—making medication abortion more difficult to access and potentially less available in some areas.
AI-generated from the bill text — verify against the official text.
Likely supporters & opponents
Likely support
- pro-life advocacy organizations — Stricter safety protocols for abortion drugs protect women's health and reduce access to a method they believe is harmful.
- religious groups opposing abortion — Restoring safeguards aligns with their conviction that abortion should be discouraged and made less accessible.
Likely opposition
- abortion-rights advocacy organizations — Reimposing stricter REMS requirements restricts women's access to a safe, FDA-approved medication and is based on outdated safety concerns.
- medical associations and reproductive-health providers — Current REMS requirements are already sufficient for safety, and stricter rules create unnecessary barriers to care and contradict medical evidence.
AI-inferred typical positions based on the bill’s substance — general stakeholder categories, not confirmed endorsements.
Should I support this?
Likely helpful for Christian families
From a Christian perspective that values the sanctity of life, this bill would help protect unborn life by making abortion medication harder to access. However, the practical and ethical effects on women's health and autonomy are significant trade-offs that Christian families may weigh differently depending on their broader convictions about law, compassion, and competing goods.
An AI assessment from a Christian-family perspective — religious freedom, parental rights, and freedom in education — not legal or voting advice.
Official summary
A bill to require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.
Sponsors
- Josh Hawley (R)
Status timeline
- 2025-05-06Read twice and referred to the Committee on Health, Education, Labor, and Pensions.S
H = House · S = Senate · A = Assembly